Modified VEGF and PDGF with improved angiogenic properties

Details for Australian Patent Application No. 2006279462 (hide)

Owner Ludwig Institute for Cancer Research Licentia Ltd.

Inventors Keskitalo, Salla; Uutela, Marko J. T.; Karpanen, Terhi; Pajusola, Katri; Jeltsch, Markku M.; Eriksson, Ulf; YlaHerttuala, Seppo; Alitalo, Kari; Tammela, Tuomas

Agent Griffith Hack

Pub. Number AU-A-2006279462

PCT Pub. Number WO2007/022287

Priority 60/708,226 15.08.05 US

Filing date 15 August 2006

Wipo publication date 22 February 2007

International Classifications

C07K 14/515 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/022287 Priority application(s): WO2007/022287

14 August 2008 Alteration of Name

  The name of the applicant has been altered to Vegenics Limited

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279464-Modeling application development in the petroleum industry

2006279454-Chemically modified short interfering nucleic acid molecules that mediate rna interference